Search results
Regeneron Reverses On Better-Than-Feared Eylea Sales
Investor's Business Daily· 4 days agoHigh-dose Eylea came in at $200 million, beating expectations for $189 million, Leerink Partners analyst David Risinger said in a report. The high dose...
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 6 days agoAn increase in profits from Dupixent and further uptake of Eylea HD are likely to have aided...
Regeneron Misses Profit Estimates on Weaker Eylea and Dupixent Sales
US News & World Report· 4 days agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation - Regeneron...
Benzinga· 4 days agoEylea US sales fell 16% to $1.2 billion, primarily due to changing market dynamics, resulting in...
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Motley Fool via Yahoo Finance· 4 days ago(Regeneron shares the rights to Dupixent with Sanofi.) Both should continue driving solid top-line...
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters via Yahoo Finance· 4 days agoRegeneron has been looking to switch Eylea patients to the high-dose 8 milligram version as the eye...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks via Yahoo Finance· 4 days agoIn August 2023, the FDA approved Eylea HD (higher dose of Eylea) for the treatment of patients with...
Earnings call: Regeneron reports steady growth, prepares for new launches By Investing.com
Investing.com· 4 days ago(NASDAQ: REGN) reported a solid start to 2024, with first-quarter revenues showing a 7% increase...
Regeneron records mixed results for Q1 as Eylea revenues fall
Crain's New York Business· 4 days agoThe slight dip was driven by decreases in sales of one eye disease drug, Eylea. While Schott predicted that the macular degeneration therapy would bring in $2.2 billion in sales, the medication ...